Abstract
Esterase D levels from 200 retinoblastoma patients have been measured in an attempt to identify individuals carrying deletions of chromosome region 13q14. In this series 75% had bilateral tumours and 23% were familial. Of nine patients identified as having low esterase D levels, five had not previously been diagnosed as deletion carriers. These observations demonstrate the benefit of screening retinoblastoma populations for esterase D deficiency.
Original language | English (US) |
---|---|
Pages (from-to) | 164-167 |
Number of pages | 4 |
Journal | Human Genetics |
Volume | 72 |
Issue number | 2 |
DOIs | |
State | Published - Feb 1986 |
Externally published | Yes |
ASJC Scopus subject areas
- Genetics
- Genetics(clinical)